Fracture Risk in Prostate Cancer during Hormonal Therapy

Publisher： Karger

E-ISSN： 1661-7657|10|2|111-112

ISSN： 1661-7649

Source： Current Urology, Vol.10, Iss.2, 2017-05, pp. : 111-112

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Hormonal Therapy of Prostate Cancer: Is There Any News?

By  

Urologia Internationalis, Vol. 63, Iss. 1, 1999-12 ,pp. : 80-85

Karger

Access to resources Recommend Favorite

Prostate Cancer, Osteoporosis and Fracture Risk

By  

Gerontology, Vol. 52, Iss. 2, 2006-02 ,pp. : 107-110

Karger

Access to resources Recommend Favorite

Assessing the risk of bone fracture among postmenopausal women who are receiving adjuvant hormonal therapy for breast cancer

By Bell R.   Lewis J.  

Current Medical Research and Opinion, Vol. 23, Iss. 5, 2007-05 ,pp. : 1045-1051

Informa Healthcare

Access to resources Recommend Favorite

The Limited Significance of a Longer Duration of Neoadjuvant Hormonal Therapy prior to Radical Prostatectomy for High-Risk Prostate Cancer in Japanese Men

By  

Urologia Internationalis, Vol. 77, Iss. 2, 2006-08 ,pp. : 122-126

Karger

Access to resources Recommend Favorite

Hormonal Predictors of Prostate Cancer

By  

Urologia Internationalis, Vol. 79, Iss. 1, 2007-07 ,pp. : 13-18

Karger

Access to resources Recommend Favorite